Viewing StudyNCT00087724



Ignite Creation Date: 2024-05-05 @ 11:34 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00087724
Status: TERMINATED
Last Update Posted: 2012-06-07
First Post: 2004-07-12

Brief Title: A Randomized Study to Evaluate FK962 in Subjects With Mild to Moderate Alzheimers Disease
Sponsor:
Organization: Astellas Pharma Inc

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 510
Enrollment Type: None
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE2
Observational Models:
Time Perspective List:
Who Masked List: